STAT3 and cancer: In addition to Erk1/2 signaling, other studies have shown that the expression of MMP-2/9 is also regulated by the STAT3 pathway [38,39,46,47], and activation of STAT3 is also associated with drug resistance of cancer cells [48,49,50].